Timber Pharmaceuticals CEO David Tierney receives $1.1M in 2019

Timber Pharmaceuticals reports 2019 executive compensation

By ExecPay News

Published: May 22, 2019

Timber Pharmaceuticals reported fiscal year 2019 executive compensation information on May 22, 2019.
In 2019, seven executives at Timber Pharmaceuticals received on average a compensation package of $403K, a 49% decrease compared to previous year.
Average pay of disclosed executives at Timber Pharmaceuticals
David S. Tierney, Chief Executive Officer, received $1.1M in total. 85% of Tierney's compensation, or $958K, was in option awards. Tierney also received $169K in salary.
Anja Krammer, Former President and Director, received a compensation package of $590K, which decreased by 52% compared to previous year. 42% of the compensation package, or $249K, was in salary.
John Koconis, Chief Executive Officer, earned $280K in 2019.
Kin F. Chan, Executive Vice President of Research and Technology, received $270K in 2019, which decreases by 58% compared to 2018.
Zachary Rome, Chief Operating Officer, earned $195K in 2019.
Steven Bosacki, Chief Executive Officer, received $185K in 2019.
Greg Kitchener, Chief Financial Officer, earned $174K in 2019, a 66% decrease compared to previous year.

Related executives

David Tierney

Timber Pharmaceuticals

Chief Executive Officer

Anja Krammer

Timber Pharmaceuticals

Former President and Director

Kin Chan

Timber Pharmaceuticals

Executive Vice President of Research and Technology

Greg Kitchener

Timber Pharmaceuticals

Chief Financial Officer

John Koconis

Timber Pharmaceuticals

Chief Executive Officer

Zachary Rome

Timber Pharmaceuticals

Chief Operating Officer

Steven Bosacki

Timber Pharmaceuticals

Chief Executive Officer

You may also like

Source: SEC filing on May 22, 2019.